Literature DB >> 18679773

The silent (R)evolution of polymeric nucleic acid therapeutics.

Ernst Wagner.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18679773     DOI： 10.1007/s11095-008-9689-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  36 in total

Review 1.  Development of biomaterials for gene therapy.

Authors:  S Han; R I Mahato; Y K Sung; S W Kim
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

Review 2.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

Review 3.  Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.

Authors:  Achim Aigner
Journal:  J Biotechnol       Date:  2006-01-18       Impact factor: 3.307

4.  Nomenclature for synthetic gene delivery systems.

Authors:  P L Felgner; Y Barenholz; J P Behr; S H Cheng; P Cullis; L Huang; J A Jessee; L Seymour; F Szoka; A R Thierry; E Wagner; G Wu
Journal:  Hum Gene Ther       Date:  1997-03-20       Impact factor: 5.695

Review 5.  DNA and RNA aptamers: from tools for basic research towards therapeutic applications.

Authors:  Henning Ulrich; Cleber A Trujillo; Arthur A Nery; Janaina M Alves; Paromita Majumder; Rodrigo R Resende; Antonio H Martins
Journal:  Comb Chem High Throughput Screen       Date:  2006-09       Impact factor: 1.339

6.  Infectious poliovirus RNA: a sensitive method of assay.

Authors:  A Vaheri; J S Pagano
Journal:  Virology       Date:  1965-11       Impact factor: 3.616

Review 7.  Vectors for airway gene delivery.

Authors:  Pamela B Davis; Mark J Cooper
Journal:  AAPS J       Date:  2007-01-19       Impact factor: 4.009

8.  Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response.

Authors:  Marie-Elise Bonnet; Patrick Erbacher; Anne-Laure Bolcato-Bellemin
Journal:  Pharm Res       Date:  2008-08-16       Impact factor: 4.200

9.  Enhancement of the plaque-forming capacity of poliovirus ribonucleic acid with basic proteins.

Authors:  C E SMULL; E H LUDWIG
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

10.  EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.

Authors:  Alexei Shir; Manfred Ogris; Ernst Wagner; Alexander Levitzki
Journal:  PLoS Med       Date:  2005-12-06       Impact factor: 11.069
View more
  3 in total

1.  Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier.

Authors:  David Schaffert; Melinda Kiss; Wolfgang Rödl; Alexei Shir; Alexander Levitzki; Manfred Ogris; Ernst Wagner
Journal:  Pharm Res       Date:  2010-08-06       Impact factor: 4.200

2.  Influence of the molecular weight of bioreducible oligoethylenimine conjugates on the polyplex transfection properties.

Authors:  Haijun Yu; Verena Russ; Ernst Wagner
Journal:  AAPS J       Date:  2009-06-06       Impact factor: 4.009

3.  Cyanobacteria produce N-(2-aminoethyl)glycine, a backbone for peptide nucleic acids which may have been the first genetic molecules for life on Earth.

Authors:  Sandra Anne Banack; James S Metcalf; Liying Jiang; Derek Craighead; Leopold L Ilag; Paul Alan Cox
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.